Polymorphisms in the prostate-specific antigen gene promoter do not predict serum prostate-specific antigen levels in African-American men

Prostate Cancer and Prostatic Diseases

Volumn 9, Issue 1, 2006, Pages 50-55

  Beebe Dimmer, J L ^a,b   Lange, L A ^c   Cain, J E ^a   Lewis, R C ^a   Ray, A M ^a   Sarma, A V ^a,b   Lange, E M ^c,d   Cooney, K A ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF MICHIGAN SCHOOL OF PUBLIC HEALTH   (United States)

^c UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^d IL   (United States)

Author keywords

Prostate specific antigen; PSA gene; Single nucleotide polymorphism

Indexed keywords

GENOMIC DNA; PROSTATE SPECIFIC ANTIGEN;

ADULT; AFRICAN AMERICAN; AGED; ALLELE; ARTICLE; BLOOD SAMPLING; CANCER RISK; CANCER SCREENING; CONTROLLED STUDY; DIAGNOSTIC VALUE; GENE IDENTIFICATION; GENETIC SCREENING; GENOTYPE; GLEASON SCORE; HETEROZYGOSITY; HOMOZYGOSITY; HUMAN; MAJOR CLINICAL STUDY; MALE; PREDICTION; PRIORITY JOURNAL; PROMOTER REGION; PROSTATE CANCER; RISK ASSESSMENT; RISK FACTOR; SINGLE NUCLEOTIDE POLYMORPHISM; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE; VALIDATION PROCESS;

ADULT; AFRICAN AMERICANS; AGED; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; PROGNOSIS; PROMOTER REGIONS (GENETICS); PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; TUMOR MARKERS, BIOLOGICAL;

EID: 33644926988     PISSN: 13657852     EISSN: 14765608     Source Type: Journal    
DOI: 10.1038/sj.pcan.4500840     Document Type: Article

References (23)

1. Jemal A, Murray T, Ward E, Samuels A, Tiwari RC, Ghafoor A et al. Cancer Statistics 2005. Ca Cancer J Clin 2005; 55: 10-30.
2. Bostwick DG, Burke HB, Djakiew D, Euling S, Ho SM, Landolph J et al. Human prostate cancer risk factors. Cancer 2004; 101: 2371-2490.
3. Stamey TA, Yang N, Hay AR, McNeal JE, Freiha FS, Redwine E. Prostate-specific antigen as a serum marker for adenocarcinoma of the prostate. N Engl J Med 1987; 317: 909-916.
4. Grossfeld GD, Carroll PR. Prostate cancer early detection: A clinical perspective. Epidemiol Rev 2001; 23: 173-180.
5. Meitz JC, Edwards SM, Easton DF, Murkin A, Ardern-Jones A, Jackson RA et al. HPC2/ELAC2 polymorphisms and prostate cancer risk: Analysis by age of onset of disease. Br J Cancer 2002; 87: 905-908.
6. Kim J, Coetzee GA. Prostate specific antigen gene regulation by androgen receptor. J Cell Biochem 2004; 93: 233-241.
7. Cramer SD, Chang BL, Rao A, Hawkins GA, Zheng SL, Wade WN et al. Association between genetic polymorphisms in the prostate-specific antigen gene promoter and serum prostate-specific antigen levels. J Natl Cancer Inst 2003; 95: 1044-1053.
8. Lewontin RC. The interaction of selection and linkage. I. General considerations; heterotic models. Genetics 1964; 49: 49-67.
9. Schaid DJ, Rowland CM, Tines DE, Jacobson RM, Poland GA. Score tests for association between traits and haplotypes when linkage phase is ambiguous. Am J Hum Genet 2002; 70: 425-434.
10. Cooney KA, Strawderman MS, Wojno KJ, Doerr KM, Taylor A, Alcser KH et al. Age-specific distribution of serum prostate-specific antigen in a community-based study of African-American men. Urology 2001; 57: 91-96.
11. Diamandis EP, Yousef GM. Human tissue kallikrein gene family: A rich source of novel disease biomarkers. Expert Rev Mol Diagn 2001; 1: 182-190.
12. Rao A, Chang BL, Hawkins G, Hu JJ, Rosser CJ, Hall MC et al. Analysis of G/A polymorphism in the androgen response element I of the PSA gene and its interactions with the androgen receptor polymorphisms. Urology 2003; 61: 864-869.
13. Xue WM, Coetzee GA, Ross RK, Irvine R, Kolonel L, Henderson BE et al. Genetic determinants of serum prostate-specific antigen levels in healthy men from a multiethnic cohort. Cancer Epidemiol Biomark Prev 2001; 10: 575-579.
14. Medeiros R, Morais A, Vasconcelos A, Costa S, Pinto D, Oliveira J et al. Linkage between polymorphisms in the prostate specific antigen ARE1 gene region, prostate cancer risk, and circulating tumor cells. Prostate 2002; 53: 88-94.
15. Xu J, Meyers DA, Sterling DA, Zheng SL, Catalona WJ, Cramer SD et al. Association studies of serum prostate-specific antigen levels and the genetic polymorphisms at the androgen receptor and prostate-specific antigen genes. Cancer Epidemiol Biomark Prev 2002; 11: 664-669.
16. Nam RK, Zhang WW, Trachtenberg J, Jewett MA, Emami M, Vesprini D et al. Comprehensive assessment of candidate genes and serological markers for the detection of prostate cancer. Cancer Epidemiol Biomark Prev 2003; 12: 1429-1437.
17. Wang LZ, Sato K, Tsuchiya N, Yu JG, Ohyama C, Satoh S et al. Polymorphisms in prostate-specific antigen (PSA) gene, risk of prostate cancer, and serum PSA levels in Japanese population. Cancer Lett 2003; 202: 53-59.
18. Xue W, Irvine RA, Yu MC, Ross RK, Coetzee GA, Ingles SA. Susceptibility to prostate cancer: Interaction between genotypes at the androgen receptor and prostate-specific antigen loci. Cancer Res 2000; 60: 839-841.
19. Gsur A, Preyer M, Haidinger G, Zidek T, Madersbacher S, Schatzl G et al. Polymorphic CAG repeats in the androgen receptor gene, prostate-specific antigen polymorphism and prostate cancer risk. Carcinogenesis 2002; 23: 1647-1651.
20. Chiang CH, Chen KK, Chang LS, Hong CJ. The impact of polymorphism on prostate specific antigen gene on the risk, tumor volume and pathological stage of prostate cancer. J Urol 2004; 171: 1529-1532.
21. Tekin A, Atsu N, Ozen H. Daily variability of serum prostate-specific antigen in men over 50 years of age. Int Urol Nephrol 2001; 33: 641-644.
22. Dejter Jr SW, Martin JS, McPherson RA, Lynch JH. Daily variability in human serum prostate-specific antigen and prostatic acid phosphatase: A comparative evaluation. Urology 1988; 32: 288-292.
23. Heeringa SG, Alcser KH, Doerr K, Strawderman M, Cooney K, Medbery B et al. Potential selection bias in a community-based study of PSA levels in African-American men. J Clin Epidemiol 2001; 54: 142-148.